Coronavirus (COVID-19): are pre-existing cardiovascular comorbidities associated with COVID-19 severity and what is the rate of subsequent cardiovascular complications?
Vanessa Jordan
+ Author Affiliations
- Author Affiliations
New Zealand Cochrane Fellow, University of Auckland, Auckland, New Zealand. Email: v.jordan@auckland.ac.nz
Journal of Primary Health Care 13(2) 189-190 https://doi.org/10.1071/HC19562
Published: 29 June 2021
Journal Compilation © Royal New Zealand College of General Practitioners 2021 This is an open access article licensed under a Creative Commons Attribution 4.0 International License
References
[1] Pellicori P, Doolub G, Wong CM, et al. COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies. Cochrane Database of Syst Rev. 2021; Art. No. CD013879| COVID‐19 and its cardiovascular effects: a systematic review of prevalence studies.Crossref | GoogleScholarGoogle Scholar |
[2] World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID-19 11 March 2020.
[3] Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020; 116 1666–87.
| COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.Crossref | GoogleScholarGoogle Scholar | 32352535PubMed |
[4] Corrales-Medina VF, Taljaad M, Yende S, et al. Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults. Am Heart J. 2015; 170 306–12.e6.
| Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults.Crossref | GoogleScholarGoogle Scholar | 26299228PubMed |
